Profil Institut für Stoffwechselforschung GmbH

Running trials

• Recruiting

  A Single and Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP6590 in Participants With Normal Weight, Overweight and Obesity

  NCT07721597· Early phase 1· Source

• Recruiting

  Bioavailability, Biopotency and Food Effect Study of SCD0503 Compared to Subcutaneous Regular Human Insulin

  NCT07634770· Phase 1· Source

• Recruiting

  A Research Study Investigating the Effect of NNC0497-0040 in Healthy Participants, Participants With Overweight or Obesity, and Participants With Type 1 Diabetes With Overweight or Obesity

  NCT07578584· Phase 1· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity2 recruiting
• Type 1 diabetes2 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Terminated

  Vonafexor in Patients With Impaired Renal Function and Suspected MASH (Metabolic Dysfunction-associated Steatohepatitis)

  NCT06939816· Phase 2· Source

• Completed

  A Trial Comparing Pharmacokinetics, Safety and Tolerability of Two Subcutaneous Concentrations of Dapiglutide

  NCT06758583· Phase 1· Source

• Terminated

  CK-0045 Proof-of-concept Study in Participants With Overweight / Obesity and Type 2 Diabetes

  NCT06611930· Phase 2· Source

• Terminated

  A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570

  NCT06000891· Phase 1· Source

• Completed

  A Research Study Looking at the Safety of Multiple Doses of ZP8396 and How it Works in the Body of Healthy Participants

  NCT05613387· Phase 1· Source

• Completed

  A Research Study of a New Medicine NNC0519-0130 in Healthy People, People With High Body Weight and People With Type 2 Diabetes.

  NCT05363774· Phase 1· Source